In a controversial move, the Trump administration canceled a $45 million grant awarded to Oregon State University (OSU) in 2018. The funding was intended for research into microfluidics and inkjet technology, areas with significant potential in fields like healthcare, biotechnology, and manufacturing.
The Department of Energy (DOE) withdrew the grant in 2019, citing concerns that the project did not meet its criteria for high-priority research. The DOE argued that the project’s focus on basic science was not aligned with its mission to address national energy needs and innovation.
Critics of the decision warned that it could hinder progress in key technologies, such as microfluidics, which could revolutionize medicine and environmental monitoring. Supporters of the grant, including OSU officials, stressed that the research had broad applications and could foster long-term economic growth.
The cancellation sparked debate over the U.S.’s commitment to funding scientific advancements. While the Trump administration defended the decision as fiscally responsible, many saw it as a missed opportunity to support cutting-edge research with far-reaching benefits.
